Department of Clinical Virology, Institute of Liver and Biliary Sciences, Vasant Kunj, New Delhi, 110 070, India.
Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, 110 070, India.
Indian J Gastroenterol. 2024 Apr;43(2):475-484. doi: 10.1007/s12664-024-01536-y. Epub 2024 Mar 9.
Sepsis remains a global health burden associated with significant morbidity and mortality. Bacteria are known to be the predominant pathogens in sepsis; however, viral etiologies in sepsis are still under diagnosed. Respiratory viral pathogens have been previously linked to sepsis, but the knowledge of incidence, disease burden and mortality of viral-induced sepsis remains limited. This study aimed at understanding the role of respiratory viral infections in the causation of sepsis in liver disease patients.
In this retrospective study, the clinical records of liver disease patients with influenza-like illness, whose requests for respiratory viral testing were received from January 2019 to December 2022, were reviewed. Respiratory viruses were identified using FilmArray 2.0 respiratory panel (BioFire Diagnostics, Utah, USA).
Of 1391 patients tested, a respiratory viral etiology was detected in 23%. The occurrence of sepsis was seen in 35%. Among these, isolated viral etiology with no other bacterial/fungal coinfection was found in 55% of patients. Rhinovirus/Enterovirus was found as the most common underlying viral etiology (23.4%). The sepsis prevalence was higher among patients with associated comorbidities (45%) and decompensated cirrhosis (84%). On multi-variable analysis, no factor was found independently associated with sepsis-related mortality.
This study underlines the importance of isolated viral etiology in causation of sepsis among liver disease patients. Patients with comorbidities, older age and decompensated cirrhosis are at an increased risk of developing sepsis and are associated with poorer outcomes. Accurate and timely identification of the viral etiology in sepsis would prevent the misuse of antibiotics and improve overall patient care.
败血症仍然是一个全球性的健康负担,与显著的发病率和死亡率有关。细菌是败血症的主要病原体;然而,败血症的病毒病因仍未得到充分诊断。呼吸道病毒病原体以前与败血症有关,但关于病毒引起的败血症的发病率、疾病负担和死亡率的知识仍然有限。本研究旨在了解呼吸道病毒感染在肝病患者败血症发病中的作用。
在这项回顾性研究中,回顾了 2019 年 1 月至 2022 年 12 月期间因流感样疾病而要求进行呼吸道病毒检测的肝病患者的临床记录。使用 FilmArray 2.0 呼吸道检测试剂盒(美国犹他州 BioFire Diagnostics)鉴定呼吸道病毒。
在 1391 名接受检测的患者中,有 23%的患者检测出呼吸道病毒病因。35%的患者发生了败血症。在这些患者中,55%的患者仅存在病毒病因,无其他细菌/真菌感染。鼻病毒/肠道病毒被认为是最常见的潜在病毒病因(23.4%)。有合并症(45%)和失代偿性肝硬化(84%)的患者败血症患病率较高。多变量分析发现,没有任何因素与与败血症相关的死亡率独立相关。
本研究强调了在肝病患者中,单纯病毒病因在败血症发病中的重要性。有合并症、年龄较大和失代偿性肝硬化的患者发生败血症的风险增加,且预后较差。在败血症中准确、及时地识别病毒病因可防止抗生素的滥用,从而改善整体患者护理。